The cell surface phenotype of peripheral blood lymphocytes (PBL) of systemic lupus erythematosus (SLE) patients was characterized with the anti-2H4 monoclonal antibody that defines the human suppressor inducer subset. The T4+2H4' population of cells has been shown to be critical for the activation of T8+ suppressor cells. Patients with SLE had a markedly decreased percentage of T4+2H4+ cells (13±2%) in their PBL compared with normal controls (21±1%) (P < 0.001). This reduction was greatest in patients with active SLE, especially those with renal disease. Serial analysis of patients with SLE and renal disease showed a correlation between percent positive circulating T4+2H4+ cells and disease activity. Moreover, there was a significant correlation between a low percentage of T4+2H4+ cells and decreased suppressor-inducer function in autologous mixed lymphocyte reaction-activated T4+ cells from SLE patients. Thus, a deficiency exists in SLE patients with active renal disease in the T4+2H4' suppressor-inducer T cell subset.
Introduction
Systemic lupus erythematosus (SLE)' is a multisystem disease in which B cell hyperactivity results in the generation of hypergammaglobulinemia and autoantibodies (1) (2) (3) . Abnormalities ofsuppressor T cell function have been reported in patients with SLE (4-7); these could be important in the predisposition to or perpetuation of disease activity. Nevertheless, the suppressor cell defect has not been well characterized. Such a defect could result from any of several causes: a numerical or functional deficiency in the suppressor-effector cells or their precursors, a deficiency in inducers ofsuppressor cells, an increase in helper cell activity, or possible abnormal function of cells that interfere with suppression (contrasuppressor cells).
In earlier studies, when anti-T4 and anti-T8 monoclonal antibodies were initially defined (8-9), we found that SLE patients with multisystem involvement but without renal disease 1.Abbreviations used in thispaper: AMLR, autologous mixed lymphocyte reaction; FITC, fluorescein isothiocyanate; JRA, juvenile rheumatoid arthritis; SLE, systemic lupus erythematosus. had a high T4/T8 ratio due to a decrease in the number of circulating T8 cells (10) . In contrast, patients with SLE manifested by severe renal disease and/or thrombocytopenia had a low ratio of T4/T8 cells (1 1, 12) . Nevertheless, many SLE patients had normal T4/T8 ratios (1 1, 12) . Thus, this ratio alone was insufficient to define a precise defect of the immunoregulatory circuit in these patients.
Previous studies demonstrated that anti-T cell antibodies found in the serum of some patients with active juvenile rheumatoid arthritis (JRA) are reactive with -40% of T4' cells (13) and that the T4+JRA' subset of T4' cells which reacted with JRA anti-T cell antibodies induces suppressor function. In contrast, the T4+JRA-subset functions as the inducer of B cell Ig synthesis in the same system (14) . We have recently developed a monoclonal antibody, anti-2H4 (15) . This (15, 16) and an antigen-specific antibody production system (17) . Thus, anti-2H4 antibody has similar reactivity to JRA anti-T cell antibodies.
We have now utilized this antibody to characterize peripheral blood lymphocytes from SLE patients. Patients with active SLE had a significantly smaller percentage of circulating T4+2H4' suppressor-inducer cells than normal individuals. In fact, patients with active SLE and renal disease had the greatest reduction in the percentage of T4+2H4' cells in their peripheral blood lymphocytes (PBL).
Methods
Isolation of lymphocytes. Peripheral blood mononuclear lymphocytes were separated from heparinized venous blood by Ficoll-Hypaque gradient density centrifugation (Pharmacia Fine Chemicals, Piscataway, NJ). The absolute number of peripheral lymphocytes from active SLE patients (0.1-1.5 X 106 cells/cm3) was less than that from inactive SLE patients (0.5-2.0 X 106 cells/cm3) or that from normal controls (0.8-3.0 X 106 cells/cm3). In some experiments, peripheral blood mononuclear cells were further separated into E-rosette positive (E+) and E-rosette negative (E-) populations with 5% sheep erythrocytes (Microbiological Associates, Bethesda, MD) as previously described (13, 14) . The T cell population obtained was > 94% reactive with a monoclonal antibody, anti-T3, which defines an antigen present on all mature peripheral T cells (8) . Furthermore, T4' cells were isolated by anti-Ig coated plates as described (17) . The purity of T4' cells were > 95%.
Separation of T4+ cells by anti-Ig coated plates. T4' cells were separated into T4+2H4' and T4+2H4-subpopulations by anti-Ig coated plates as described (17) . In brief, 12 X 106 cells were exposed to I ml of anti-2H4 (a 1:125 dilution ofascites) for 30 min at 4VC and then washed to remove excess antibody. 12 X 106 cells suspended in 3 ml media were then applied to a goat anti-mouse Ig antibody-coated plastic plate (Fisher Scientific Co., Pittsburgh, PA). After 70 min of incubation at 40C, nonadherent and adherent populations were collected. The adherent population is consistently 95% positive with anti-2H4 antibody, and nonadherent cells are consistently 4% positive. These populations are referred to 2H4' and 2H4-cells, respectively.
Patients. The sample population consisted of 69 patients with SLE satisfying the diagnostic criteria ofthe American Rheumatism Association (18) . All patients were monitored at the Arthritis Branch of the National Institute of Arthritis, Diabetes, Digestive and Kidney Diseases, Bethesda, MD. Disease activity scores were determined by two physicians on a 0-to-4 scale and averaged at the time of blood drawing on the basis of multisystem disease activity including fever, rash, arthritis, serositis, vasculitis, nephritis, and central nervous system disease. Furthermore, the disease activity of patients with renal disease was determined at the time of blood drawing whether the patients had active renal disease and/or activity in extrarenal manifestations. Seven patients were untreated, 35 patients were receiving low-dose corticosteroid therapy (5-20 mg prednisone every other day), 20 patients were receiving intermediate doses of steroids (20 mg prednisone every other day to 35 mg prednisone per day) and seven patients were receiving > 35 mg of prednisone per day. None of the patients had received cytotoxic drugs during the preceding 6 mo at the time of blood drawing. Blood samples were drawn at least 24 h after the last steroid dose. The normal control population consisted of 60 sex-and age-matched healthy individuals who had no significant illness. We judged SLE patients with activity scores 2 1 to have active disease and < 1 to have inactive disease. Patients with known renal disease were those with hematuria (2 10 RBC/hpf), proteinuria (2 I g/24 h), RBC casts, or cellular casts either currently or in the past. In these patients, lupus renal disease was confirmed by biopsy.
Production ofmonoclonal antibodies. Three monoclonal antibodies termed anti-T4, anti-T8, and anti-2H4 were used in the present study. Their production and characterization are described elsewhere (8, 14 (15, 16) and an antigen-specific antibody production system ( 17) . Analysis (13, 14) .
Statistical methods. The Fisher's exact test or the two-tailed unpaired t test was used as indicated to calculate P values.
Results
PBL expression ofT4 and 2H4 in patients with SLE and normal controls are summarized in Table I . The circulating lymphocyte population in normal individuals is composed of 54±2% 2H4' lymphocytes, ofwhich only a portion are T4+2H4' suppressorinducer T cells (21 ± 1% of total). In patients with SLE, the percentage of 2H4 bearing lymphocytes (50±2%) in the peripheral blood was only marginally decreased; however, the percentage of T4+2H4' suppressor-inducer cells (13±2%) in the peripheral blood was markedly decreased (Table I) . Patients with active SLE had the greatest reduction in percentages of T4+2H4' cells (Table I) . T4/T8 ratios did not significantly differ between normal controls and SLE patients. Fig. 1 shows representative two-color profiles of peripheral blood lymphocytes coexpressing the T4 and 2H4 antigens in blood of a normal control, a patient with active SLE and one with inactive SLE. This study was done using anti-T4 biotin with Texas Red avidin and monoclonal anti-2H4 conjugated to The data in Table I suggested a relationship between a reduction in T4+2H4' cells and SLE disease activity. The relationship between the percentage of circulating T4+2H4' cells in patients and their disease activity was therefore plotted. Fig. 2 shows the relationship between the percentage ofT4+2H4' cells in PBL and disease activity in the entire group of SLE patients. A lower limit of two standard deviations from the mean percentage ofT4+2H4' cells in the peripheral blood ofnormal controls is slightly above 7%. Thus, a patient with 7% T4+2H4' cells among their PBL has a significantly lower than normal percentage of circulating T4+2H4' cells. There was a significant negative correlation between percent positive T4+2H4' cells and disease activity (ay = -0.278, P < 0.05). The relationship between the percentage of circulating T4+2H4' cells and disease activity in SLE patients with renal involvement was examined. As shown in Fig. 3 , there was a significant negative correlation between percent positive T4+2H4' cells and disease activity (ay = -0.375, P < 0.05). Patients with no known renal disease had a lower To determine whether the percent T4+2H4' circulating cells of a given patient changed with disease activity, samples were taken from seven patients on at least three occasions. Fig. 4 shows a two-color profile of PBL coexpressing the T4 and 2H4 antigens from an individual with renal disease. As shown in Fig.  4 A, there were no detectable T4+2H4' cells in the patient's PBL at the time ofinitial evaluation when the disease was moderately active (activity score 1; T4+2H4+: 3.1%). As shown in Fig. 4 B, T4+2H4' cells were detectable 1 mo later at a time when the disease activity was somewhat diminished (activity score 0.5; T4+2H4+: 8.5%). More importantly, when disease activity was completely inactive 6 mo later, the percent positive T4+2H4' cells returned to normal levels (activity score 0; T4+2H4+: 20%) (Fig. 4 C) . In this case, the patient did not receive corticosteroids (20) . Furthermore, the T4+2H4+ subset of cells proliferated maximally in AMLR and the suppressor-inducer activity of T4+ cells generated in the AMLR response was attributable to an activated T4+2H4' suppressorinducer subset (20) . To ascertain these points, T4+, T4+2H4+, or T4+2H4-cells from normal individuals were triggered with autologous non-T cells for 7 d and added to freshly isolated PBL from a healthy single donor to assess their effect on PWMdriven IgG synthesis. As shown in Table III , AMLR-activated T4+ and T4+2H4+ cells had a strong suppressor activity in a dose-dependent fashion. In contrast, AMLR-activated T4+2H4+ cells had no such effect. It should be noted that there was no suppression observed when AMLR-activated T4+ cells were added to B+T4 cells with PWM in the absence of T8+ cells, thus indicating that these cells functioned as suppressor inducers (20) . Therefore, these results reconfirmed that AMLR-activated T4+2H4' cells but not T4+2H4-cells showed the suppressorinducer activity.
Next, to determine whether the decreased percent of T4+2H4+ suppressor-inducer cells was associated with the defect of generating suppressor activity by AMLR-activated T4 cells, we studied the relationships between percent T4+2H4+ cells and percent suppression by AMLR-activated T4 cells from SLE patients with known renal disease. To examine suppressor activity, T4 cells from patients with SLE were triggered in AMLR for 7 d and then AMLR-activated T4 cells (2 X 104) were added to 1 X I0O freshly isolated PBL from a healthy single donor to assess their effect on PWM-driven IgG synthesis. As shown in Fig. 6 , 15 patients with SLE were studied in this fashion and a significant correlation between a low percentage of T4+2H4+ cells and a decreased percent suppression of PWM-driven IgG synthesis by AMLR-activated T4 cells from SLE patlents was found ( = 0.90, P < 0.001). These results further support the notion that the T4+2H4+ cells may play an important role in generating suppressor-inducer activity in vivo.
To exclude the possibility that the low percent of T4+2H4+ cells in patients with active renal disease may be due to the presence of autoantibodies bound to cell membrane antigens interfering with anti-2H4 staining, we selected patients who had anti-T cell antibodies in their sera as previously described (21) . Then T cells from normal donors were incubated with these sera for 1 h at 4°C, and after extensive washing these cells were stained with anti-2H4 antibody or anti-T4 antibody and goat anti-mouse Ig FITC. As shown in Table IV , incubation of T cells with SLE sera did not interfere with anti-2H4 and anti-T4 staining of T cells. Thus, these results indicated that the above possibility was unlikely.
Discussion
Anti-2H4 reacts with -40-50% of T4+ lymphocytes and 50-60% of T8+ lymphocytes in man (15) . In vitro studies indicated that the T4+2H4+ subset of lymphocytes exhibited the inducer of suppressor function similar to that previously described as IrO.9O (p'o.oo1) Figure 6 . The relationship between the percent of T4+2H4+ cells and the percent suppression of PWMdriven synthesis by AMLR-activated cells from patients with SLE. Percent suppression was calculated as described in Table III. the T4+JRA+ subset (13, 14) that induces or activates T8V cells to exert suppressor function. In contrast, the T4+2H4-subset of lymphocytes induced helper function in both a PWM-stimulated Ig synthesis (15, -16) and an antigen-specific antibody production system (17) . Furthermore, the T4+2H4+ subset proliferates maximally in response to autologous non-T cells but poorly to soluble antigen stimulation. The T4+2H4-subset, in contrast, proliferates relatively poorly to autologous non-T cells but well to soluble antigen stimulation.
The present study utilizes the anti-2H4 monoclonal antibody to characterize the cell surface phenotype of peripheral blood lymphocytes in SLE patients with varying disease activity and in subgroups of patients with and without known renal disease. In previous studies, SLE patients with multisystem involvement but without renal disease often had a high T4/T8 ratio due to a decrease in the number of T8' (10) (11) (12) . In contrast, patients with SLE manifested by severe renal disease and/or thrombocytopenia tended to have a low T4/T8 ratio due to a decreased percent of T4' inducer cells and increased percent of T8' cells (11, 12) . Nevertheless, many patients with SLE had a normal T4/T8 ratio and shared some clinical features of the other two groups (12) . Thus, the ratio itself was insufficient to define a precise defect of the immunoregulatory circuit in most SLE patients. The anti-2H4 antibody adds another parameter to the analysis of human regulatory cells that may prove useful for the characterization of the cellular basis for the defects in patients with autoimmune diseases. Furthermore, the present study shows that there was a significant correlation between a low percent of T4+2H4+ cells and a decreased percent of PWMdriven IgG synthesis by AMLR-activated T4' cells from SLE patients.
Because patients with SLE manifest lymphopenia (22-24) and impaired T cell function (25) (26) (27) (28) , a relationship between the anti-lymphocyte antibodies and this impaired T cell function has long been sought. The precise mechanism of loss of circulating T4+2H4+ cells in patients with active renal disease is not clear at the present time. We have previously shown, however, that many patients with SLE have anti-T cell antibodies in their sera that react with a functional T4+ suppressor-inducer subset of lymphocytes (21) . Thus, sera of the patients with a loss of T4+2H4+ cells could have anti-T cell antibodies that are reactive with the T4+2H4+ subset of cells and play some role in their elimination from the circulation.
Although some patients with non-renal disease had a selec- 
